West Tower Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-421
Closed -$24.3K 148
2023
Q4
$24.3K Buy
+421
New +$22.5K 0.05% 273
2023
Q3
Sell
-151
Closed -$8.17K 621
2023
Q2
$8.17K Buy
+151
New +$7.89K 0.01% 454

Other funds holding BSX

West Tower Group's BSX Position: Q1 2024 in Review

West Tower Group sold out of Boston Scientific (BSX) in Q1 2024, closing a stake of 421 shares — an estimated $24.3K sold.

West Tower Group first reported a position in BSX in Q2 2023 and held it in 2 quarters. The position peaked at $24.3K in Q4 2023. 1,222 funds tracked by Wall St. Rank hold BSX as of Q1 2024.

  • West Tower Group reported no remaining Boston Scientific position as of Q1 2024 after selling out during the quarter.
  • West Tower Group sold 421 Boston Scientific shares in Q1 2024, an estimated $24.3K.
  • West Tower Group first reported a position in Boston Scientific in Q2 2023 and held it in 2 quarters.
  • West Tower Group's Boston Scientific position peaked at $24.3K in Q4 2023.
  • 1,222 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2024.

Based on West Tower Group's 13F filing for Q1 2024, filed 14 May 2024.